News Archive of Xconomy Life Sciences

After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future02-21-17
Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M02-21-17
Argos Shares Crater on Futility Finding for Kidney Cancer Therapy02-22-17
Genomenon's Software Seeks to Give Geneticists Faster Insights02-21-17
Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking Shares02-21-17
Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device02-23-17
Aiming At P53, Cancer's Hard Target, PMV Pharma Raises $74M02-22-17
Shares in Exact Sciences Rise on Better-Than-Expected P&L Results02-23-17
Harvard's Verdine Aims to Retire, Become Full-Time FogPharma CEO02-23-17
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More02-24-17
Symbiomix Therapeutics Names David L. Stern to CEO Post02-23-17
H3 Biomedicine Promotes Peter Smith to Chief Scientific Officer02-23-17
Trump Policies, Paperwork, & More: Advice for Startup Founders02-24-17
Celgene Promotes Smith to President, Fouse to Retire02-24-17
BioCrossroads Report: Steady Growth for Life Sciences in Indiana02-24-17
Xenex Gets $38M From Essex Woodlands, Others for Germ-Zapping Robots02-24-17
Cempra Soars on Drug's Potential to Treat MRSA, Other Infections02-24-17
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy02-27-17
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills02-27-17
Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment02-27-17
Blood Simple? Grail's Cancer Screening Quest Faces Tough Questions02-04-16
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More02-05-16
Rockefeller's Tessier-Lavigne Heads Back to the Bay to Run Stanford02-04-16
Improving Odds for Women in Tech? Take Notes from Biotech02-04-16
Syngenta, NC Biotech, PSEG Solar, & More NC Innovation News02-08-16
Flint's Water, Wicab, & New Leaders: This Week's Wisconsin Watchlist02-05-16
West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More02-05-16
Houston Healthcare Firm Medical Adhesive Revolution Is Now Adhesys02-08-16
Roundup: San Antonio Fund, Filamet Labs, 5miles, Decisio, BioHouston02-08-16
San Antonio's TRTF Reboots Seed VC Fund02-08-16
Biogen's Scangos on Pricing, Deals, Hemophilia, Alzheimer's & More02-09-16
12 San Diego Life Sciences Startups to Watch in 201602-09-16
BioCryst Stock Tanks After Rare Disease Drug's Phase 2 Failure02-08-16
Top Engineer Behind Google's Rise Will Lead Grail In Cancer-Test Quest02-10-16
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel02-10-16
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery02-10-16
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO02-11-16
TRImaran Licenses WSU Compounds to Develop Neuro Drugs02-11-16
Teaching Innovation: Rice Professor Reviews Accelerator Programs02-10-16
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More02-11-16
Rice Business Plan Competition Adds ?People's Choice? Award04-17-15
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups04-17-15
Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals04-17-15
West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More04-16-15
Early Bird Ends Today for Houston 2035: Innovating the City's Future04-16-15
Levin Steps in as Ovid CEO, Confirms Plan to Target Rare Neuro Diseases04-16-15
Doudna, Berkeley Gain Expert's Backing In CRISPR Patent Fight04-15-15
Big Day For Biotech IPOs as Berkeley's Aduro Doubles In Price04-15-15
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials04-15-15
Announcing Boston 2035: Innovating the Future Starts Now04-15-15
Healthcare Is Transforming Regardless of What Happens to the ACA04-15-15
What's Hot in Boston Biotech: The Photos04-15-15
Join Us May 6 at the Hutch to Discuss Seattle Biotech's Wild Ride04-14-15
Massachusetts Healthcare, Internet Companies Lead Pack in VC Chase04-14-15
 A New Day for Digital DNA04-14-15
Wisconsin Roundup: Arrowhead, Cellular Dynamics, Madworks, & More04-14-15
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor04-14-15
VC Funding Slows as Big Funds Crowd into Late-Stage Venture Deals04-14-15
Curoverse Begins Trial Run for Open Source Genomics Tool04-14-15
Houston's TCC Aims to Help NASA Find Energy, Biotech Partners04-13-15
Voyager Lands $60M, ?Crossover? Backers, For Neuro Gene Therapies04-13-15
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO04-13-15
East Coast Biotech Roundup: Cellectis, Bristol, What's Hot & More04-13-15
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More04-10-15
Startups Strut on Stage at UNC Innovation Showcase04-10-15
Tax Time Alert: Key Things to Know About Founders Preferred Stock04-10-15
UW Updating IP Policies to Fit ?21st Century Research University?04-10-15
Seven Takeaways From ?What's Hot in Boston Biotech?04-10-15
The Story Behind Cellular Dynamics? Sale to Fujifilm04-09-15
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug04-09-15
Clocking In Next Year, Juno's New HQ Keeps A Hand On Seattle History04-08-15
Texas Roundup: New funds, Salesforce Buys Toopher, Chin Heads to UT04-08-15
Alzheon Gets $10M to Take Castoff Alzheimer's Drug Into Pivotal Test04-08-15
After raising $76M in Series E Round, aTyr Pharma Files for IPO04-07-15
With $35M Infusion, True North Moves Rare Disease Drug Into Clinic04-07-15
Tasso, GenTegra Push Ahead With DARPA-Backed Home Blood-Draw Device04-07-15
Juno, Novartis End CAR-T Patent Fight, With Juno A Little Richer04-06-15
Prenatal Screener Natera Grabs $55M, Considers Cancer Test04-06-15
Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More04-06-15
Gene Therapy's Rebirth Continues With Bristol, UniQure Cardio Deal04-06-15
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place04-06-15
Wisconsin Roundup: Ebola, Kiio, The Water Council, Uber, & More04-03-15
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More04-03-15
Doudna's Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech04-02-15
West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More04-02-15
MD Anderson's Chin Heads to UT to Lead Efforts to Fight Diabetes04-02-15
Seattle's Iconic Helix Biotech Campus to Be Expedia's New Home04-02-15
Shareholder Challenges Fujifilm's Cellular Dynamics Acquisition04-02-15
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds04-02-15
Days After $22M Raise, Gelesis Files for IPO04-01-15
Bioforward, Wisconsin Biotech Trade Group, Names 2nd CEO in 7 Months04-01-15
NuVasive CEO Resigns After Probe of Personnel and Policy Violations04-01-15
Q1 Texas News: Investments, Accelerator Startups & Mark Cuban at SXSW04-01-15
Equity Crowdfunding Backers Clash Over Fundraising Limits in States04-01-15
Garabedian's Rocky Road at Sarepta Ends With Abrupt Resignation04-01-15
ATyr Pharma Raises $76M Round to Advance Physocrine Drugs04-01-15
Xconomy Boston's Top Stories of Q1 2015: Editor's Picks04-01-15
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push04-01-15
Algal Scientific Scores $7M Series B, Expands in Animal Health03-31-15
At Q1's End, Three Texas Technology Startups Announce New Funds03-31-15
Spruce Nabs $15M Series A to Connect Dermatologists and Patients03-31-15
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck03-31-15
From Iceland to White House, Precision Medicine's Promises & Hurdles03-31-15
Arch, Flagship to Anchor NYCEDC's $150M NY Biotech Fund03-30-15
Fujifilm Snaps Up Cellular Dynamics To Grow Stem Cell Business03-30-15
Novan Therapeutics Lands $50M to Tackle Acne, HPV03-30-15
Teva Agrees to Buy San Diego's Auspex Pharmaceuticals for $3B+03-30-15
Horizon Pays $1.1 Billion for Hyperion's Rare Disease Drugs03-30-15
Peter Thiel Brings Libertarian Standup Routine to Harvard03-30-15
Novartis Bets $250M-Plus on Aduro's Immuno-Oncology Work03-30-15
In New Gene-Editing World, Doudna Applies Both Brake and Gas Pedal03-27-15
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More03-27-15
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More03-27-15
As Pharma Collaborations Gain Importance, GSK Opens Second Outpost03-27-15
Seattle's Gilliland, Nelsen, Hood, Franklin & More to Gather May 603-26-15
What's Hot in Boston Biotech? Here's the Agenda03-26-15
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill03-26-15
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date03-26-15
Run An Early Stage Tech or Life Sciences Company? Heads Up03-26-15
Ex-Teva CEO Levin Is Back With Startup Aimed at Rare Neuro Disorders03-25-15
EchoPixel's Virtual Anatomy Models FDA-Cleared for Diagnosis, Surgical Planning03-24-15
Semma Secures $44M to Develop Diabetes Stem Cell Therapy03-24-15
Alexion Deal in Hand, Blueprint Readies IPO Pitch03-23-15
Austin's Aeglea Biotherapeutics Raises $44M for Cancer Drug03-23-15
Raleigh-Durham Roundup: Heat Biologics, nCino, Scioderm, & More03-23-15
ImmunoGen Surges on $440M Takeda Deal For 'smart Bomb? Cancer Drugs03-23-15
Fastest Turtle: Healthcare Investing and the U.S. Economy03-23-15
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?03-23-15
His Attacker Found Guilty, UCSD's Steve Dowdy ?Not Looking Back?03-21-15
Biogen Drug Shows Early Promise in Slowing Alzheimer's Decline03-20-15
Somna Makes Case for Simple Device Before Drugs, Surgery for Reflux03-19-15
With Data in Hand, Amicus Preps For Drug Filings in U.S., Europe03-19-15
Kyoto Prize Winner Robert Langer on Innovations to Come03-19-15
Ginkgo Bioworks Grabs $9M Series A For Building Organisms03-18-15
Wisconsin Roundup: Gener8tor, Epic, Lucigen, 3D Printing, & More03-18-15
Meerkat and the Live Streaming Phenomenon at SXSW: A Tech Timestamp03-18-15
How to Build a Men's Health Startup: MHB Labs Gets Romulus Cash03-18-15
With Asklepion Deal, Retrophin Gets a New Drug?And a Voucher03-18-15
New York's Life Science Disruptors: The Photos03-18-15
With $43M, Nimbus Sheds ?Discovery? Tag, Heads to First Clinical Test03-18-15
Swallow Solutions Gulps $1.1M To Push Oral Muscle Rehab Device Sales03-17-15
Glooko Gets $16M Injection to Upgrade Digital Diabetes Product03-17-15
Business Analytics Firm Birst Brings In $65M Series F03-17-15
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital03-17-15
Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow03-16-15
Roundup: HelloWorld, Blackstone, MI Celebrates Small Business & More03-16-15
Six Takeaways From ?New York's Life Science Disruptors?03-16-15
Valeant Boosts Bid For Salix By $1B, Endo Withdraws03-16-15
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More03-16-15
Goodybag, Aceable Among Capital Factory's ?A-List? Startups at SXSW03-13-15
Seattle Roundup: Spaceflight Industries, Expedia, Magicflix, & More03-13-15
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More03-13-15
23andMe Adds On: More About The Gene-Test Maker's Drug R&D Ambitions03-12-15
Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial03-12-15
Medical Adhesive Revolution Aims for a Better Wound-Sealing Therapy03-12-15
23andMe Pharma? That's the Plan, Says the Genetic Test Maker03-12-15
Ex-TechTown Head Hopes Collaboration Will Help All American Cities03-12-15
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M03-12-15
After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug03-12-15
At Acadia, ?Mistakes Were Made,? A Drug Is Delayed & the CEO Is Out03-11-15
Salix Bidding War Erupts as Endo Tops Valeant's Offer03-11-15
Stratatech Eyes Phase 3 Trial Of Regenerative Tissue For Burn Wounds03-11-15
MicroVentures Brings Venture Investing to the (Accredited) Masses03-11-15
Heat Biologics Launches $10M Stock Offering; CFO To Move On03-11-15
Music As Therapy? PureTech's 'sync Project? Aims to Prove It03-11-15
Houston 2035: A Glimpse of the Innovative American City of the Future03-11-15
In Move That Spells Relief, Zogenix Sells Painkiller to Pernix03-11-15
Madison Vaccines Expands Series A To Advance Prostate Cancer Drugs03-10-15
In Oncology Shuffle, Amgen To Shutter Onyx, Lay Off About 30003-10-15
RayVio Absorbs $9.3M for UV Technology to Clean Water and Air03-10-15
Companion Diagnostic Specialist AltheaDx Withdraws IPO03-10-15
Hope to See You Thursday at ?New York's Life Science Disruptors?03-10-15
Ocular's Long-Lasting Eye Drug Tech Passes First Late-Stage Test03-10-15
DARA BioSciences Nabs U.S. Rights to Oral Thrush Drug03-10-15
Evercharge and Others Nab Last Finalist Slots in $650K Challenge Cup03-10-15
CTI Goes Up, And Down, And Back Up On Phase 3 Myelofibrosis News03-09-15
22 Startups Join First Class of Texas Medical Center's TMCx Accelerator03-09-15
Radius Health Recharges IPO After Two Week Hiatus05-21-14
Science and Art: Why Choose? A Biotech Entrepreneur's Dual Life05-21-14
Boston 2034: The Big Agenda for Our June 10 Innovation Conference05-21-14
1Q VC Data: What Just Happened?05-21-14
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch05-20-14
After Time For Family, Reflection, VC Samuels Emerges At Venrock05-19-14
Ophthotech, Novartis Team up on $1B Deal for Eye Drug05-19-14
West Coast Biotech Roundup: Lumena/Shire, Isis, Janssen Labs & More05-16-14
Check Out Our Napa Summit Agenda?Get Your Invite for June 2-3 Event05-16-14
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More05-16-14
Gelesis Resurfaces With $12M, Preps First Weight Loss Data05-16-14
With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round05-16-14
NeuMoDx and Jeff Williams Capitalize on Lessons Learned at Handylab05-15-14
At the Threshold of a New Digital Health Landscape05-15-14
The Davis Dilemma: New Energy for Innovation, But Where to Grow?05-15-14
Foundation Gives $31.2M to Support UW Entrepreneurial Researchers05-14-14
Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial05-14-14
New Janssen Labs Incubator Could Bring Up to 50 Companies to South SF05-14-14
Xconomy Surveys Innovation in the Sacramento-Davis Corridor05-14-14
With New Calendar App, Owaves Takes First Step to Healthy Lifestyle05-13-14
SolveBio Grabs $2M to Make Genomics Easier for Programmers05-13-14
Nonprofit Aims to Boost Early-Stage Healthcare Startups in Milwaukee05-13-14
Shire Pays Over $260M Upfront in IPO Detour for San Diego's Lumena05-12-14
LTI Corrals $5M to Exploit Link Between Gaucher, Parkinson's05-12-14
Shire Pays Over $260M Upfront in IPO Detour for San Diego's Lumena05-12-14
Tesaro Climbs on Phase 3 Data for Nausea Drug05-12-14
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up05-12-14
Digital Health Check-Up: More Dollars, Fewer Bracelets05-12-14
Radius Health Yanks IPO, Cites Market Conditions05-09-14
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More05-09-14
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More05-09-14
10 Things to Know About BEN, Blackstone, and Colorado's Gazelles05-08-14
Biotech IPO Slump Deepens as Alder Prices Below Range05-08-14
Outside San Diego, Illumina Looks to Wisconsin for Key R&D05-08-14
Hutch Starts Search for New Prez as Corey Steps Down05-08-14
NPS Pharma's Francois Nader on the Megadeal Fallout for Biotechs05-08-14
San Diego's Synthorx Adds To Genetic Alphabet, Aims for Bio-Products05-07-14
Texas Roundup: Capital Factory, DEC, UT-Dallas, & Austin Biosciences05-07-14
Get a Window on the Innovation Future at Boston 2034 on June 1005-07-14
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark05-06-14
MCW's Clarke Wants to Build Critical Mass of Medical Entrepreneurs05-06-14
Deal Aims to Grow ?Humanized? Organs in Pigs for Transplantation05-06-14
San Diego's Ambrx Files for IPO to Advance Antibody-Drug Conjugates05-05-14
4 Weeks Until Our Napa Summit on June 2-3?Request Your Invitation05-05-14
Organizing For Aging?An Investment Imperative05-05-14
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More05-02-14
San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs05-02-14
The Experiment Begins: Y Combinator Admits First Biotech Startups05-02-14
Wireless Health Summit: Barriers to Adoption and Tools for Change05-01-14
Halcyon Biomedical Aims to ?Wash? Blood for Safer Transfusions05-01-14
Lightstone Closes $172M Fund for Early-Stage Biotechs05-01-14
At Two-Year Mark, JOBS Act Is Regulation Even A Biotech Can Love05-01-14
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 305-01-14
New Napa Speakers: Kawasaki on Startups, Ashenfelter on Wine04-30-14
Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases04-30-14
BioPharma Learns From Marvel, Begins Real Life Search For ?X-Men?04-30-14
CleverPet Feeder is Like a Dance Dance Revolution for Dogs04-29-14
GlobeImmune Sets $15 to $17 Price Range in Second IPO Attempt04-29-14
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M04-29-14
Indi Reels In $47M To Push Launch Of Lung Cancer Diagnostic04-29-14
What's Hot in Boston Biotech: The Photos04-29-14
Why Would Amazon Want its Own Smartphone, Anyway?04-29-14
Verdezyne Gets $48M to Advance Industrial Biotechnology in Malaysia04-29-14
OncoGenex's Long Wait For Cancer Drug Ends With a Phase 3 Stumble04-28-14
GroundMetrics Lands $2.7M to Expand Geophysical Survey Technology04-28-14
In Need Of Revenues, Aastrom Buys Sanofi's Cell Therapy Products04-25-14
How A Kidney Drug Almost Torpedoed Concert Pharma's IPO04-25-14
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More04-25-14
Domain Elite Invests $6.5M in GI Device Maker to Expand in China04-25-14
Amid Court Fight and Trial Pauses, Juno Closes First Round at $176M04-24-14
San Diego Life Sciences Roundup: Illumina, Vital Therapies, and More04-24-14
MD Anderson Leverages IBM Watson in Cancer-Fighting Efforts04-24-14
Two San Francisco Startups Sharing In Third Rock's Rich Third Fund04-24-14
Life Sciences Research in Washington Delivers Economic Punch04-23-14
Texas Roundup: Neos, See Forge, Ilumi, M-87, Food on the Table04-23-14
Kala Pharma Grabs $22.5M More For Eye Drugs04-23-14
ProNAi Therapeutics Closes on $59.5M to Advance Cancer Drug04-22-14
Molecular Match Uses HealthIT Software for Better Clinical Trials04-22-14
7 Takeaways From ?What's Hot in Boston Biotech?04-22-14
Digital Health Event Highlights Innovation, Wireless Clinical Trials04-21-14
A Big Day for Xconomy: Introducing Elise Craig and Alex Lash04-21-14
Sarepta to Resubmit Application for Duchenne Drug, Shares Boom04-21-14
Just 7 Tickets Left for Our What's Hot in Cancer Event April 2204-21-14
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push04-20-14
MoneyTree Reports $35.6M in MI Venture Deals Last Quarter04-18-14
Pacific Northwest Venture Activity ?Healthy? in First Quarter04-18-14
Vyrix Files for $29M IPO to Develop Anti-Premature Ejaculation Drug04-18-14
Alkermes CEO Richard Pops on Building Big and Playing Well with Pharma04-18-14
VCs Invest $243M in San Diego Startups in Q1, Tech Drought Continues04-18-14
First-Quarter Venture Funding at $9.6B in U.S., Highest Since 200104-18-14
With IPO Expectations Reset (Again), Vital Therapies Begins Trading04-17-14
Edico Genome Aims at Data Processing Bottleneck in Genome Sequencing04-17-14
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents04-16-14
HardTech Labs Enrolls 4 in Cross-Border Manufacturing Accelerator04-16-14
Vyrix Forms Partnership to Commercialize Premature Ejaculation Drug04-15-14
East Coast Biotech Roundup: Agios, Spero, Cerulean, & More04-11-14
Scripps Unveils New Drug Development Arm, Signs J&J as First Partner04-15-14
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia04-15-14
Office on iPad: Reports of its Demise Have Been Greatly Exaggerated04-14-14
San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More04-11-14
Roundup: Aastrom, Gale, STEM summer camps, Beringea, HelloWorld04-11-14
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs04-11-14
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO04-10-14
Celladon Gets FDA's ?Breakthrough Therapy? Status for Gene Therapy04-10-14
Agios Taps Wall Street Off Early Data, Aims For $75M04-10-14
Software VC Tucks Fund for UC San Diego Deals into New Venture Fund04-09-14
Medical Test Maker Venaxis Raises $18.4M, Files for FDA Approval04-09-14
Spero Emerges With $3M, Backing From Roche, And Plans to Disarm Bugs04-09-14
Announcing Napa Summit 2014: Get An Invite to Xconomy's Elite Confab04-08-14
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug04-08-14
Adaptive Corrals $105M to Ramp up Immune System Diagnostics04-07-14
Zombies, Cowboys, & Aliens Dish Up for BioHouston Chili Cookoff04-07-14
San Diego Life Sciences Roundup: Halozyme, NuVasive, Lumena, and More04-07-14
Agios's Blood Cancer Drug Shines in First Clinical Test04-06-14
Life Sciences Fund Granted Reprieve, But ?Future Is Precarious?04-04-14
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More04-04-14
San Diego's Lumena Files for IPO to Fund Liver Drug Trials04-04-14
AvidBiotics Taps Nature for Two Ways To Fight Lethal Microbes04-03-14
Xconomy Seattle's Top Stories of Q1 2014: Editor's Picks04-02-14
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking04-02-14
ZappyLab Creates Budding Social Media Network for Biologists04-01-14
Dairyland Innovation: Xconomy Wisconsin's Top Stories Since December Launch04-01-14
NY Genomics, Health Tech, Get $160M in State Support04-01-14
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund04-01-14
Lone Star Innovation: Xconomy Texas? Top Stories of Q1 201404-01-14
Countdown to the Rock Stars of Innovation Summit: Whats Going On04-01-14
Forma Gets $225M More, And a Potential Buyout, From Celgene04-01-14
Xconomy Boston's Top Stories of Q1 2014: Editor's Picks03-31-14
San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More03-31-14
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge03-31-14
Learn the Future of New England Innovation: Announcing Boston 203403-31-14
Appearing Briefly at Your Next Conference: ?Whac-A-Mole? Speakers03-31-14
West Health Investment Fund Sinks $7.5M into Reflexion Health03-28-14
AirStrip Acquires Sense4Baby for Monitoring High-Risk Pregnancies03-28-14
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More03-28-14
San Diego's RuiYi Raises $15M for Pipeline of Biologic Therapeutics03-28-14
Syndax Plots $69M IPO For Cancer Drug's Stretch Run03-28-14
FDA Panel Gives Exact's Colon Cancer Test Ringing Endorsement03-27-14
Washington Lawmakers Ax Life Sciences Fund, Tech Incentives03-27-14
GenSpera's Targeted ?Death Carrot? Toxin in Trials for Two Cancers03-27-14
What's Hot in Boston Biotech: Here's the Agenda for April 1603-27-14
Rock Stars of Innovation Present: Have You Ever Seen the Rainmakers?03-27-14
Calling All Angels: Practically Anyone Can Be an Angel Investor03-26-14
Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO03-25-14
Neurophage Nabs $17M More to Hunt Down Brain Plaques03-25-14
Seattle's KinDex Gets $5M to Fight Diabetes, Burn Fat With Hops03-25-14
Gilead Following Multiple Paths Toward HIV ?Functional Cure?03-24-14
AMRI to Acquire API Manufacturer Cedarburg Pharmaceuticals for $41M03-24-14
Celgene Gets FDA Nod For Oral Arthritis Drug03-21-14
San Diego Life Sciences Roundup: Digirad, AMN Healthcare, and More03-21-14
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More03-21-14
NinePoint Gets $34M From Corning, Others, For Medical Imaging Tech03-20-14
Former Gen-Probe CEO Partners with PE Firm in Hunt for Buyout Deals03-19-14
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M03-19-14
NY Genome Center, IBM to Bring Watson to Genomics03-19-14
Cross-Border Innovation Groups Establish Manufacturing Accelerator03-18-14
Calithera Targets Otherworldly Metabolism of Tumor Cells03-18-14
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone03-18-14
Colorado-based GlobeImmune Gives IPO a Second Shot, Aims for $35M03-17-14
Wisconsin Roundup: Tech Transfer, Supercomputers, Stem Cells03-17-14
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal03-17-14
San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More03-17-14
Intercept Ends Roller Coaster Weekend With Phase 3 Victory03-16-14
Seattle Roundup: Kickstarter, Kineta, Ride-Share Regs, Lively03-14-14
After Raising More Cash, PatientSafe Solutions Eyes Foreign Markets03-14-14
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More03-14-14
Sage Therapeutics Grabs $38M More For CNS Drugs03-13-14
Partnership with AnaptysBio Gives Tesaro Entrée to Immuno-Oncology03-13-14
Capital Factory Pitch Day Offers Peak at Upcoming Austin Innovation03-12-14
New York's Life Science Disruptors: The Photos03-12-14
Amid Cyber-Theft Onslaught, Calit2 Begins New Program Focused on IP03-11-14
Get a Shot, Have Some Bread: ImmusanT's Plan For a Celiac Vaccine03-11-14
HIV Treatment Outlook Buoyed by Sangamo Gene Therapy03-10-14
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO03-10-14
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines03-10-14
10 Takeaways From New York's Life Science Disruptors03-10-14
Genentech Joins ?What's Hot in Cancer Immunotherapy? Apr. 2203-07-14
San Diego Life Sciences Roundup: Acadia, Ignyta, Tracon, & More03-07-14
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More03-07-14
Edison Shedding Light on Energy Production in Diseased Cells03-06-14
Dallas Biotech Neos Therapeutics Raises $15.5M for ADHD Drugs03-05-14
Colorado's Ampio Pharmaceuticals Raises $63M+ in Stock Offering03-05-14
Farewell, Xconomy Readers. I?m Going to Climb a New Mountain03-05-14
Biogen, Eisai Join Up in Alzheimer's Drug Pact03-05-14
See You Tomorrow at New York's Life Science Disruptors03-05-14
San Diego's Connect Names Pharma Executive Greg McKee as CEO03-04-14
Craig Venter's Latest Startup Gets $70M To Sequence Loads of Genomes03-04-14
Merck Joins ?What's Hot in Cancer Immunotherapy? Apr. 2203-04-14
With Gene Therapy, VentriNova Aims to Mend Broken Hearts03-04-14
Supreme Court Should Scale Back Securities Class Actions03-04-14
Why It's Time to Retire the Term ?Life Sciences?03-04-14
RainDance, Angling For an IPO, Adds $16.5M From GE Ventures, Others03-03-14
PacBio, the Post-Hype Sleeper of Genomics03-03-14
Rebooted Texas Cancer Agency Funds Biotech Firms02-28-14
San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More02-28-14
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More02-28-14
How to Tell When a Startup Is Ready for Investment02-28-14
Revamped Radius Health Looks to Cash In With $86M IPO02-27-14
Cellular Dynamics, Seizing the Present, Turns Stem Cells into Cash02-27-14
New York's Life Science Disruptors on March 6: Here's the Agenda02-26-14
Drug Development 101: A Story About OncoGenex and the FDA02-26-14
Tests for Tumor DNA in Blood May Yield New Ways to Hit Cancer02-26-14
Celladon Could Go Far Under Servier Collaboration, Licensing Deal02-25-14
Elliott Sigal, Bristol's Former R&D Chief, on Life After Big Pharma02-25-14
Colorado-based Drug Developer Ampio Releases Plan to Sell 8M Shares02-24-14
BioHouston Life Science Forum Spotlights Texas Biotech Innovation02-24-14
Hiring in Biotech is Tricky. But Algorithms Won?t Save the Day02-24-14
?All Hat, Ton of Cattle??02-22-14
San Diego Life Sciences Roundup: Lithera, CardioCell, and More02-21-14
Isis Shares Climb on Early Data for Rare Spine Disorder Drug02-21-14
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More02-21-14
Are Universities Creating Too Many Biotech Startups?02-20-14
Join Xconomy for ?What's Hot in Cancer Immunotherapy? on April 2202-20-14
2014 Trends in Early-Stage Life Sciences Investment02-20-14
New San Diego Biotech Charts Stem-Cell Therapies for Heart Disease02-19-14
Madison Biotech Supplier Goes Lean to Stave Off Foreign Competitors02-19-14
Tumor Cells? Weird Appetites for Amino Acids Are Aeglea's Targets02-19-14
Balancing Power Between Biotech and Big Pharma Benefits Both02-19-14
Gates Foundation Hires Second Biotech VC to Connect With Startups02-18-14
Lithera Raises Additional $8M for Injectable Drug to Melt Belly Fat02-18-14
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim02-18-14
Ex-Harvard Bio Prez Leads Spin-Off's Plan to Make Engineered Organs02-18-14
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA02-17-14
San Diego Life Sciences Roundup: Cadence, Mast, Illumina, and More02-14-14
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More02-14-14
MD Revoultion Raises $7M for Web-based Health and Fitness Program02-14-14
Pivothead Smart Glasses Offer New Point of View on Everyday Life02-13-14
Retrophin Shares Boom Following Manchester Pharma Buyout02-13-14
Precision Medicine Healthcare Summit, Feb. 21: Saver Rate Ends Today02-13-14
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share02-13-14
Illumina, Yuri Milner Open Genomics Startup Accelerator in SF02-12-14
Qualcomm Ventures? QPrize Contest Pulls in VCs, Especially Overseas02-12-14
Pharmacyclics, J&J Get FDA Nod for Chronic Lymphocytic Leukemia Drug02-12-14
Miscarriage Mysteries Create New Market for Natera02-12-14
Third Rock's Voyager Hunts For CNS Disorders With Gene Therapy02-12-14
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow02-12-14
Novelos Becomes Cellectar, Returns to Madison Roots02-11-14
The Young and Proven Biotech VCs From 2012. Where Are They Now?02-10-14
Austin's Lumos Pharma Gets $14M for Creatine Disorder Therapy02-07-14
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More02-07-14
San Diego Life Sciences Roundup: Auspex, Biocept, Halozyme & More02-07-14
Ann Arbor's 3D Biomatrix Clears Final Hurdle to Patent02-06-14
3 Takeaways From Madison Startup Fair: More, Faster, Better02-06-14
Precision Medicine Healthcare Summit on Feb. 21: Here's the agenda02-06-14
Eleven Prices IPO Below Projected Range, Grabs $50M02-06-14
Relypsa Aims to Delay Need for Costly Dialysis in Kidney Patients02-05-14
Vaccine Developer Genocea Prices IPO at $12 Per Share02-05-14
Myriad Genetics Acquires Crescendo Bioscience for $270M02-04-14
Acucela Pins Down $162M IPO in Japan to Develop Eye Drugs02-04-14
Peregrine Semiconductor Bets Big on Industry Shift in Wireless Chips02-04-14
Esser Taps Former Wisconsin Funeral Trust Advisors for New Fund02-03-14
Biopharmaceutical Haiku02-03-14
The $1K Genome? So What? Illumina Is On a Quest for World Domination02-03-14
San Diego Life Sciences Roundup: Accelrys, Celladon's IPO, and More01-31-14
Hunting For Brain Plaques, Neurophage Turns to a Virus01-31-14
Dicerna Shares Triple on First Trading Day, Close at $4601-30-14
France's Dassault Systèmes to Buy San Diego's Accelrys for $750M01-30-14
Eric Schadt, Acorda's Cohen Join NY's Life Science Disruptors Lineup01-30-14
ZappRx Gets $1M From Atlas, SR One to E-Prescribe Specialty Meds01-30-14
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests01-30-14
J&J Opens Data Vault to Yale, in ?Unprecedented? Transparency Move01-30-14
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday01-30-14
$40M Establishes New Center for Stem Cell Genomics in Bay Area, SD01-30-14
Augmented Reality Meets Nursing in Evena's Vein-Hunting Glasses01-29-14
Epic Sciences Compiling Data on Ultra-Sensitive Cancer Diagnostic01-29-14
Thong Le Takes Over at Accelerator, With Eyes on Seattle and NYC01-29-14
With Record $275M Gift, Sanford-Burnham Unveils New 10-Year Plan01-28-14
Life Sciences Innovation Key for UT's New Medical School Dean01-28-14
What the World Needs Now Is (Probably Not) a Pill for Perfect Pitch01-27-14
Epizyme Heads Back to Wall Street, Plans $140M Raise01-27-14
Marshfield Clinic Aims to Boost Tech Transfer With Cleveland's Help01-27-14
Gene Therapy Lurches Ahead, Sees Thorny Future Questions on Price01-27-14
Milwaukee Pharma Supplier Fontarome Chemical in Receivership01-24-14
Using Cutting-Edge Science and Technology Against an Age-Old Disease01-24-14
Texas Biotech Leaders Doubt CPRIT Will Get its Groove Back01-24-14
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More01-24-14
San Diego Life Sciences Roundup: Shire, Illumina, Tandem, and More01-24-14
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market01-24-14
Early Bird Ends Soon for Feb. 21 Healthcare Summit: Get Your Invite01-23-14
Robertson Gives Rockefeller $25M For Drug Discovery01-23-14
Join Us, And New York's ?Life Science Disruptors,? On March 601-23-14
Social Media & Cancer Drugs: Conversation, not Promotion01-23-14
Venture Highlights of 2013: Early Stage Deals, Mobile, and New York01-23-14
Lisa Suennen Leaves Psilos Group for ?New Adventure? in Healthtech01-22-14
RenovoRx Catheter Pinpoints Destination for Injected Fluids01-22-14
With Dermagraft Sale, Shire Jettisons Business Acquired 3 Years Ago01-22-14
With Biotech IPO Outlet, San Diego Venture Funding at 15-Year Low01-21-14
Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin01-21-14
Wisconsin 2013 VC Activity Drops, Shifts to Software from Biotech01-21-14
The Big Guys Have Lost Their Iron Grip, and It's All Good01-20-14
Juno Deal Drives Standout Quarter for VC Investment in Seattle01-17-14
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More01-17-14
East Coast Biotech Roundup: JP Morgan Edition01-17-14
2013 VC Funding Tops $29B, and Software Continues to Eat the World01-17-14
WSU Student-Led SIB Medical Technologies Prepares Prototype for Market01-16-14
Larry Smarr Says Quantified Self is Awakening, Despite Zeo's Failure01-16-14
Announcing Our Exclusive Healthcare Summit Feb. 21: Request an Invite01-16-14
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment01-15-14
San Antonio Launches HeroX Challenge By Targeting Mexican Innovators01-15-14
Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido01-14-14
ProNAI Therapeutics Raises $12M Series C Round01-14-14
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal01-14-14
Biodesix Secures $26M in New Funds to Market Cancer Treatment Test01-13-14
Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion01-13-14
Alkermes Nabs $250M It Doesn?t Need, But Could Fend Off Barbarians01-13-14
Madison Vaccines Closes $8M Series A Round for Prostate Treatment01-13-14
What Biotech Pros Will Be Chirping About at JP Morgan This Week01-13-14
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme01-13-14
Mile High Roundup: New Tech Gets Healthy, CU Contest Kicks Off01-10-14
Tal Medical Gets NIMH Backing for Fast-Acting Depression Therapy01-10-14
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More01-10-14
Milwaukee, Chicago VCs Bullish on Wisconsin Startups01-10-14
San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More01-10-14
EPA Taps Stemina to Screen Drugs for Possible Birth Defects01-09-14
Space Flight Launched Today Includes CU Studies of Antibiotics, Ants01-09-14
Akili, Pfizer, and the Rise of Videogame Brain Therapies01-09-14
Intercept Shares Skyrocket After Liver Drug Nails Mid-Stage Study01-09-14
Sangamo, Biogen Team up to Make Drugs For Blood Disorders01-09-14
Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest01-09-14
With New Funding, Avelas Moves Closer to a Color-Coded Map of Cancer01-09-14
Tillman Gerngross, the Scientist Turned Scientific Businessman01-09-14
Serial MedTech Inventor Tackles Surgical Scarring with ZipLine Closures01-09-14
U.S. Biomedical Research at a Precipice01-09-14